Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices

There exists a tremendous opportunity in identifying and determining the appropriate predictive and prognostic biomarker(s) for risk stratification of patients with colorectal cancers (CRCs). Circulating tumor DNA (ctDNA) has emerged as a promising prognostic and possibly predictive biomarker in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Malla, Midhun, Loree, Jonathan M, Kasi, Pashtoon Murtaza, Parikh, Aparna Raj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
REVIEW ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390824/
https://www.ncbi.nlm.nih.gov/pubmed/35839443
http://dx.doi.org/10.1200/JCO.21.02615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390824/
https://www.ncbi.nlm.nih.gov/pubmed/35839443
http://dx.doi.org/10.1200/JCO.21.02615

Ejemplares similares